Search Results - "Meazza, Raffaella"

Refine Results
  1. 1
  2. 2
  3. 3

    Role of Common-Gamma Chain Cytokines in NK Cell Development and Function : Perspectives for Immunotherapy by Meazza, Raffaella, Azzarone, Bruno, Orengo, Anna Maria, Ferrini, Silvano

    Published in Journal of biomedicine & biotechnology (01-01-2011)
    “…NK cells are components of the innate immunity system and play an important role as a first-line defense mechanism against viral infections and in tumor immune…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Tumor rejection by gene transfer of the MHC class II transactivator in murine mammary adenocarcinoma cells by Meazza, Raffaella, Comes, Alberto, Orengo, Anna M., Ferrini, Silvano, Accolla, Roberto S.

    Published in European journal of immunology (01-05-2003)
    “…The murine mammary adenocarcinoma cell line TS/A is a highly malignant MHC class II‐negative tumor. We show that transfection of TS/A cells with the MHC class…”
    Get full text
    Journal Article
  12. 12

    Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination by PUPA, Serenella M, IEZZI, Manuela, DI CARLO, Emma, INVERNIZZI, Annamaria, CAVALLO, Federica, MEAZZA, Raffaella, COMES, Alberto, FERRINI, Silvano, MUSIANI, Piero, MENARD, Sylvie

    Published in Cancer research (Chicago, Ill.) (01-02-2005)
    “…Plasmid DNA vectors encoding the full-length (VR1012/HER-2-FL) or only the extracellular and transmembrane domains (VR1012/HER-2-ECD-TM) of human (h) HER-2/neu…”
    Get full text
    Journal Article
  13. 13
  14. 14

    IL-15/IL-15Rα intracellular trafficking in human melanoma cells and signal transduction through the IL-15Rα by PERENO, Raffaele, GIRON-MICHEL, Julien, FERRINI, Silvano, AZZARONE, Bruno, GAGGERO, Alessia, CAZES, Eric, MEAZZA, Raffaella, MONETTI, Monia, MONACO, Eugenia, MISHAL, Zohar, JASMIN, Claude, INDIVERI, Francesco

    Published in Oncogene (26-10-2000)
    “…There are two IL-15 isoforms and eight isoforms for the IL-15Rα chain whose biological role is poorly understood. Here, we have analysed the intracellular…”
    Get full text
    Journal Article
  15. 15

    Different levels of control prevent interferon-γ-inducible HLA-class II expression in human neuroblastoma cells by CROCE, Michela, DE AMBROSIS, Alessandro, CORRIAS, Maria V, PISTOIA, Vito, OCCHINO, Marzia, MEAZZA, Raffaella, GIRON-MICHEL, Julien, AZZARONE, Bruno, ACCOLLA, Roberto S, FERRINI, Silvano

    Published in Oncogene (30-10-2003)
    “…The HLA class II expression is controlled by the transcriptional activator CIITA. The transcription of CIITA is controlled by different promoters, among which…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Report from the Eleventh Killer Immunoglobulin‐like Receptor (KIR) Workshop: Novel insights on KIR polymorphism, ligand recognition, expression and function by Falco, Michela, Sivori, Simona, Meazza, Raffaella, Pende, Daniela

    Published in HLA (01-08-2019)
    “…The Eleventh Killer Immunoglobulin‐like Receptor (KIR) Workshop was held in Camogli (Genoa, Italy) in October 2018. This congress brought together 113…”
    Get full text
    Journal Article
  18. 18

    ERAP1 regulates natural killer cell function by controlling the engagement of inhibitory receptors by Cifaldi, Loredana, Romania, Paolo, Falco, Michela, Lorenzi, Silvia, Meazza, Raffaella, Petrini, Stefania, Andreani, Marco, Pende, Daniela, Locatelli, Franco, Fruci, Doriana

    Published in Cancer research (Chicago, Ill.) (01-03-2015)
    “…The endoplasmic reticulum aminopeptidase ERAP1 regulates innate and adaptive immune responses by trimming peptides for presentation by MHC class I (MHC-I)…”
    Get full text
    Journal Article
  19. 19

    2B4 dysfunction in XLP1 NK cells: More than inability to control EBV infection by Pende, Daniela, Meazza, Raffaella, Marcenaro, Stefania, Aricò, Maurizio, Bottino, Cristina

    Published in Clinical immunology (Orlando, Fla.) (01-07-2019)
    “…X-linked lymphoproliferative disease 1 (XLP1) is a monogenic disorder caused by mutations in SH2D1A, resulting in the absence/dysfunction of the signaling…”
    Get full text
    Journal Article
  20. 20

    NK Cell-Based Immunotherapy for Hematological Malignancies by Sivori, Simona, Meazza, Raffaella, Quintarelli, Concetta, Carlomagno, Simona, Della Chiesa, Mariella, Falco, Michela, Moretta, Lorenzo, Locatelli, Franco, Pende, Daniela

    Published in Journal of clinical medicine (16-10-2019)
    “…Natural killer (NK) lymphocytes are an integral component of the innate immune system and represent important effector cells in cancer immunotherapy,…”
    Get full text
    Journal Article